Currently out of the existing stock ratings of Mike Kratky, 27 are a BUY (77.14%), 8 are a HOLD (22.86%).

Mike Kratky

Work Performance Price Targets & Ratings Chart

Analyst Mike Kratky, currently employed at LEERINK, carries an average stock price target met ratio of 56.22% that have a potential upside of 23.23% achieved within 87 days.

Mike Kratky’s has documented 75 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ISRG, Intuitive Surgical at 17-Jul-2026.

Wall Street Analyst Mike Kratky

Analyst best performing recommendations are on DXCM (DEXCOM).
The best stock recommendation documented was for TXG (10X GENOMICS) at 1/27/2026. The price target of $20 was fulfilled within 6 days with a profit of $1.62 (7.49%) receiving and performance score of 12.49.

Average potential price target upside

of $59.46 (17.61%) on ISRG (INTUITIVE SURGICAL).
of $22.31 (28.9%) on DXCM (DEXCOM).
of $15.58 (7.33%) on INSP (INSPIRE MEDICAL SYSTEMS).

MDT Medtronic PLC ABT Abbott Laboratories AXGN Axogen BSX Boston Scientific Corp DXCM DexCom EW Edwards Lifesciences Corp INSP Inspire Medical Systems ISRG Intuitive Surgical NPCE Neuropace PEN Penumbra PODD Insulet PRCT Procept Biorobotics Corp TNDM Tandem Diabetes Care TXG 10X Genomics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Joshua Jennings (TD COWEN)